James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Tesla Inc (TSLA), AmTrust Financial Services Inc (AFSI) and ServiceNow Inc (NOW) Are 3 of Today’s Worst Stocks

Tesla (TSLA), AmTrust Financial Services (AFSI) and ServiceNow (NOW) shareholders wound up wishing the weekend had lasted one more day.

8 of the Most Overrated Stocks on Wall Street Right Now

Some stocks are graded fairly, but a handful of the most overrated stocks deserve to be called out -- and sold sooner than later.

No, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Isn’t Doomed

Teva Pharmaceutical (TEVA) has more upside than most investors realize. Look past the Copaxone debacle, and TEVA stock is promising.

Why Royal Bank of Scotland Group PLC (RBS), Hewlett Packard Enterprise Co (HPE) and Baidu Inc (ADR) (BIDU) Are 3 of Today’s Worst Stocks

Hewlett Packard Enterprise (HPE), Royal Bank of Scotland Group (RBS) and Baidu (BIDU) ended the week on a low note.

Why Freeport-McMoRan Inc (FCX) Stock Is Much Uglier Without Indonesia

Freeport McMoRan (FCX) flinched first, effectively conceding that Indonesian regulators were holding all the cards with Papua's copper mine.